Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOVENT BIO

93.600
+1.6501.79%
Volume:5.62M
Turnover:522.29M
Market Cap:160.43B
PE:-1.47K
High:94.300
Open:91.100
Low:90.650
Close:91.950
52wk High:109.100
52wk Low:28.650
Shares:1.71B
HK Float Shares:1.71B
Volume Ratio:1.22
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.064
ROE:8.43%
ROA:2.65%
PB:10.16
PE(LYR):-1,470.03
PS:12.83

Loading ...

INNOVENT BIO (01801) Partners with Takeda Pharmaceutical Co Ltd for Global Strategic Collaboration and Issuance of Shares Under General Mandate

Stock News
·
Oct 22

Innovent Biologics and Takeda Announce Global Cancer Therapy Collaboration

Reuters
·
Oct 22

Innovent Biologics - Innovent and Takeda Will Co-Develop Ibi363 Pd-1/Il-2Α-Bias) Globally and Co-Commercialize It in U.S.

THOMSON REUTERS
·
Oct 22

Innovent Biologics - Co Also Eligible for Potential Milestones Totaling up to $10.2 Bln

THOMSON REUTERS
·
Oct 22

Innovent Biologics - Will Receive $1.2 Bln Upfront Payment, Including Strategic Equity Investment of $100 Mln by Way of Subscription

THOMSON REUTERS
·
Oct 22

Active Trading of Hong Kong Stock Connect | October 21

Stock News
·
Oct 21

Hong Kong Stock Connect Fund Flow Statistics (T+2) | October 20

Stock News
·
Oct 20

Analysis of Stock Holdings in Hong Kong Connect | October 16

Stock News
·
Oct 16

Hong Kong Stock Connect Active Trading | October 13

Stock News
·
Oct 13

China Merchants International: Limited Impact Expected from US Tariffs on Innovative Drugs for CXO Companies, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Sep 30

Innovative Drug Industry Trend Established, Advancing Global Commercialization

Stock News
·
Sep 24

Innovent Bio's Weight Loss Drug Highlights Challenges for Novo-Nordisk A/S and Eli Lilly in Chinese Market

Deep News
·
Sep 23

Morgan Stanley: Enhanced Market Recognition of Biotech Stocks Drives Outperformance, Bullish on AKESO (09926) and Others

Stock News
·
Sep 23

Hong Kong Stock Market Preview | Major Press Conference to Be Held, Port Coal Prices Break Through 700 Yuan Mark

Stock News
·
Sep 22

Innovent Biologics Gets China Nod for Second Indication of Glycemic Control Drug

MT Newswires Live
·
Sep 19

Innovent Announces Mazdutide Received Approval From China's Nmpa for Glycemic Control in Adults With Type 2 Diabetes

THOMSON REUTERS
·
Sep 19

INNOVENT BIO (01801): Mazdutide Receives NMPA Approval for Blood Sugar Control in Adult Type 2 Diabetes Patients in China

Stock News
·
Sep 19

Innovent Biologics Inc - Mazdutide Approved by China's Nmpa for Glycemic Control

THOMSON REUTERS
·
Sep 19

Innovent Biologics Announces Promising Clinical Study Results for Picankibart in Psoriasis at EADV Congress 2025

Reuters
·
Sep 16

Fangzhou Says in Partnership With Innovent to Integrate Co's H2h Digital Health Ecosystem With Innovent's Pipeline of Weight-Management Therapies

THOMSON REUTERS
·
Sep 14